A competitor's exit is raw intelligence if you know what to do with it.
Hi there and happy Wednesday,
We all watch what competitors do.
But the harder question is: What do we do when a competitor walks away from something we are considering?
A pharmaceutical company found itself in that position. A competitor had walked away from developing a fixed-dose drug combination.
At first glance, it looked like a warning sign. But it was not clear what the signal actually meant.
- Was the science flawed?
- Were the clinical results weak?
- Or did the business case simply not make sense?
The risk was making the wrong call. Walking away from a viable opportunity, or pursuing something that had already failed for good reason.
They came to us with one question:
Should we follow the signal or question it?
The 3-step approach we used to decode the signal
Here’s what we did.
Step 1: Reconstruct what actually happened
We started by gathering all available information around the abandoned asset.
This included published clinical results, investor presentations, regulatory filings, press releases, and company communications during the period.
The goal was to understand not just the outcome, but the context behind it.
Step 2: Identify likely failure points
Next, we analyzed the clinical data and looked for factors that could explain the abandonment.
We engaged regulatory experts to assess approval challenges and drug development specialists to evaluate potential scientific and commercial risks.
This helped separate speculation from likely causes.
Step 3: Evaluate market and strategic fit
Finally, we looked beyond the trial itself.
The broader market landscape was assessed, including competition, pricing pressure, and demand dynamics.
This helped determine whether the opportunity was fundamentally unattractive or simply misaligned for the original developer.
Results
The investigation revealed:
- Clinical trial challenges that could complicate regulatory approval
- A highly saturated market with strong competition
- Low price points that limited commercial upside
- A combination of scientific and economic factors behind the abandonment
The signal was real, but it was not one-dimensional.
It provided context for the client to make an informed decision rather than reacting to the competitor’s move.
What you can learn from this
Across industries, competitor actions are often treated as signals. But not all signals mean the same thing.
A company walking away from an opportunity can indicate risk, or reflect their specific constraints, strategy, or timing.
Teams that take the time to understand the “why” behind the signal make better decisions.
Without that clarity, you cannot know whether you’ve solved the problem that caused others to walk away, or whether you are stepping into the same trap.
At the same time, the right capabilities or strategy can make the difference between failure and success.
Understanding the full context is what separates the two.
If your next move depends on interpreting what others have done, the real question is not what happened. It is why it happened.
Ready to turn market signals into better decisions?
Catch up on recent insights
Contributing expert - João Guerreiro, Ph.D.



